Welcome!
We are dedicated to providing our research community with reliable and reproducible recombinant antibodies in various forms for diversified applications.
We have built both naïve and synthetic recombinant antibody display libraries for de novo antibody discovery and antibody affinity maturation.
 |
Eunice Yu Zhou, Ph.D. | Faculty Director | 415-206-3251 | rAB@ucsf.edu |
 |
James D. Marks M.D., Ph.D. | Faculty Advisor |
| Location | Hours |
|
1001 Potrero Ave Building 1, Room 170 San Francisco, CA 94143 |
Monday - Friday 8am - 5pm |
| Name | Role | Phone | Location | |
|---|---|---|---|---|
| Eunice Yu Zhou |
Faculty Director
|
415-206-3251
|
rAB@ucsf.edu
|
1001 Potrero Ave, Building 1, Room 170
|
| Service list |
| ► Multi-eachs (5) | |||
| Name | Description | Price | |
|---|---|---|---|
| m-D11 - IgG production | Inquire | ||
| m-H2 - Isolation of V genes from hybridoma | Inquire | ||
| m-S1 - Expression of scFv (1 liter) | Inquire | ||
| mA12-1 - Phase 1 of mA12 Affinity Maturation Strategy 2. VL shuffling | Inquire | ||
| mA12-2 - Phase 2 of mA12 Affinity Maturation Strategy 2. VL shuffling | Inquire | ||
| ► Single-each (18) | |||
| Name | Description | Price | |
| A11-2 - Phase 2 of A11 Affinity Maturation Strategy 1. Random mutation (error-prone PCR) | Inquire | ||
| A12-1 - Phase 1 of A12 Affinity Maturation Strategy 2. VL shuffling | Inquire | ||
| A14-1 - Phase 1 of A14 Affinity Maturation Strategy 3. 4 CDR-mutation | Inquire | ||
| Affinity Maturation Strategy 4. CDR-L3 | Inquire | ||
| Affinity Maturation Strategy 4. CDR-L3 | Inquire | ||
| D11 - IgG production | Inquire | ||
| H3 - Assembly of V genes from hybridoma | Inquire | ||
| A1 - Affinity Maturation Part 1. Antigen Preparation and Evaluation | Inquire | ||
| A11-1 - Phase 1 of A11 Affinity Maturation Strategy 1. Random mutation (error-prone PCR) | Inquire | ||
| A111 - Cell surface affinity measurement | Inquire | ||
| A112 - Affinity by KinExA - Step 1 Initial Test | Inquire | ||
| A113 - Affinity by KinExA - Step 2 Full measurement | Inquire | ||
| A14-2 - Phase 2 of A14 Affinity Maturation Strategy 3. 4 CDR-mutation | Inquire | ||
| H1 - Hybridoma IgG production and purification | Inquire | ||
| H2 - Isolation of V genes from hybridoma | Inquire | ||
| H4 - Validation of V genes from hybridoma | Inquire | ||
| S1 - Expression of scFv (1 liter) | Inquire | ||
| S2 - Expression of scFv (10 liter) | Inquire | ||
